By addressing these pivotal elements, this study aspires to provide significant insights into the potential of PSMD14 as a promising biomarker for diagnostic and therapeutic strategies in lung adenocarcinoma, ultimately advancing our understanding of tumor biology and the immune microenvironment. This evidence concerns the gene PSMD14 and lung adenocarcinoma.